Jolien Van der Jeugt

Onze Lieve Vrouwziekenhuis Hospital

Papers

5

Total Citations

87

H-Index

5

About

Jolien Van der Jeugt is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive robotic surgery for complex urologic conditions, particularly bladder cancer, benign prostatic enlargement, and pediatric renal tumors. Her major contributions include demonstrating that surgical experience significantly improves perioperative and oncological outcomes in robot-assisted radical cystectomy with intracorporeal urinary diversion—a finding drawn from a high-volume referral center and cited over 50 times. She also conducted the first comparative analysis of holmium laser enucleation of the prostate (HoLEP) versus robot-assisted simple prostatectomy (RASP) for extremely large prostates (≥200 cc), providing critical evidence for treatment selection in challenging cases. Her work extends to pediatric oncology, where she has shown the feasibility of robot-assisted nephrectomy for Wilms’ tumor. Notably, Van der Jeugt has called for a new disease-specific comorbidity index for bladder cancer patients undergoing robotic cystectomy, highlighting her commitment to refining risk stratification. With over 85 cumulative citations across her key papers, her research is shaping surgical practice and improving patient outcomes in robotic urology.

Research Focus

Key Achievements

5
H-Index
5
Papers
87
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
The Effect of Surgical Experience on Perioperative and Oncological Outcomes After Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Evidence from a Referral Centre with Extensive Experience in Robotic Surgery
52 citations · 2020
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Onze Lieve Vrouwziekenhuis Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago